Nebivolol Pliva (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Pliva, is a beta blocker presented as a tablet for oral use. It lowers blood pressure and improves cardiac function in adults with hypertension or heart failure.

GNH USA supplies Nebivolol Pliva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is indicated for cardiovascular conditions that involve elevated blood pressure or impaired heart function.

- Hypertension: reduces systolic and diastolic blood pressure, helping achieve target levels. - Heart failure: improves left ventricular ejection fraction and decreases hospitalization risk. - Left ventricular systolic dysfunction: enhances cardiac output and may delay disease progression.

Nebivolol may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Headache - Dizziness - Fatigue - Nausea

Serious or Rare Side Effects: - Severe bradycardia - Symptomatic hypotension - Allergic reactions such as rash or angioedema

When prescribing Nebivolol, clinicians should consider several precautionary measures to ensure safe use.

- Blood pressure monitoring: check baseline and periodic readings. - Cardiac function assessment: evaluate heart rate and conduction before initiation. - Hepatic impairment: use with caution in patients with severe liver disease. - Concomitant beta‑blocker therapy: avoid combining with other beta blockers unless medically justified. - Abrupt discontinuation: taper dose to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and light.

Nebivolol can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Non‑dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem): may cause excessive bradycardia or AV block. - Potent CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): increase nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely): - Other antihypertensives (e.g., ACE inhibitors, diuretics): may enhance blood pressure‑lowering effect. - Clonidine withdrawal: abrupt cessation of clonidine while on nebivolol can lead to hypertension. - Antiarrhythmic agents (class IA or III): may augment cardiac conduction effects.